Genoa Pharmaceuticals

About:

Genoa Pharmaceuticals develops therapies for the treatment of idiopathic pulmonary fibrosis.

Top Investors: Andera Partners, F-Prime Capital, Novo Holdings, RiverVest, TPG Biotech

Description:

Genoa Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies for the treatment of idiopathic pulmonary fibrosis (IPF). It develops GP-101, an aerosol pirfenidone formulation for direct inhalation delivery to the lungs for the treatment of IPF. The company was founded in 2011 and is based in San Diego, California.

Total Funding Amount:

$64.2M

Headquarters Location:

San Diego, California, United States

Founded Date:

2011-01-01

Contact Email:

info(AT)genoapharma.com

Founders:

Mark W. Surber, Richard G. Vincent

Number of Employees:

1-10

Last Funding Date:

2017-05-15

IPO Status:

Private

Industries: